Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib.

Cancer Cell
Ling LiRavi Bhatia

Abstract

BCR-ABL tyrosine kinase inhibitors (TKI) fail to eliminate quiescent leukemia stem cells (LSC) in chronic myelogenous leukemia (CML). Thus, strategies targeting LSC are required to achieve cure. We show that the NAD(+)-dependent deacetylase SIRT1 is overexpressed in human CML LSC. Pharmacological inhibition of SIRT1 or SIRT1 knockdown increased apoptosis in LSC of chronic phase and blast crisis CML and reduced their growth in vitro and in vivo. SIRT1 effects were enhanced in combination with the BCR-ABL TKI imatinib. SIRT1 inhibition increased p53 acetylation and transcriptional activity in CML progenitors, and the inhibitory effects of SIRT1 targeting on CML cells depended on p53 expression and acetylation. Activation of p53 via SIRT1 inhibition represents a potential approach to target CML LSC.

References

Apr 29, 1999·The New England Journal of Medicine·C L Sawyers
Jan 10, 2002·Cell·C Prives, J L Manley
Mar 7, 2003·Cancer Cell·Rossana TrottaBruno Calabretta
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hwei-Ling ChengKatrin F Chua
Jan 6, 2004·Science·Lyubomir T VassilevEmily A Liu
Mar 16, 2005·Nature Reviews. Molecular Cell Biology·Laura Bordone, Leonard Guarente
Jan 31, 2006·Aging Cell·Christopher KamelMichael W McBurney
Apr 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Richard T WilliamsCharles J Sherr
Mar 24, 2007·Nature Reviews. Molecular Cell Biology·Karen H Vousden, David P Lane
May 20, 2008·Cell·Yi TangWei Gu
Oct 15, 2008·Molecular Cell·Rui-Hong WangChu-Xia Deng
Dec 17, 2008·The Journal of Biological Chemistry·Valentina ZuckermanYgal Haupt
Jan 9, 2009·Cell Stem Cell·Yan LiuStephen D Nimer
Jan 10, 2009·Nature Reviews. Cancer·Christopher L Brooks, Wei Gu
Feb 27, 2009·Cancer Research·Tao LiuGlenn M Marshall
Aug 27, 2011·BMC Medicine·Anna M EiringMichael W Deininger

❮ Previous
Next ❯

Citations

Dec 25, 2012·Current Hematologic Malignancy Reports·Ross Kinstrie, Mhairi Copland
Jan 12, 2013·Current Hematologic Malignancy Reports·Wesam Ahmed, Richard A Van Etten
Apr 4, 2013·International Journal of Hematology·Takahiro Ito
Aug 31, 2012·Journal of Medicinal Chemistry·Dante RotiliAntonello Mai
Nov 24, 2012·Cell Death and Differentiation·P Y LiuT Liu
Jul 25, 2012·Nature Reviews. Cancer·Thomas O'HareMichael W Deininger
Feb 13, 2013·The Journal of Experimental Medicine·Christian SchürchAdrian F Ochsenbein
May 1, 2013·The Journal of Experimental Medicine·Satyendra K SinghPhilipp Oberdoerffer
Mar 1, 2013·Journal of the National Cancer Institute·Min ChenXiaoyan Jiang
Mar 23, 2013·Current Opinion in Hematology·WenYong Chen, Ravi Bhatia
Dec 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Girija DasmahapatraSteven Grant
Oct 4, 2013·BMC Cancer·Albrecht StenzingerWilko Weichert
Sep 29, 2012·Current Pharmaceutical Design·Santina BruzzoneAlessio Nencioni
Apr 23, 2013·Oncogene·M Roth, W Y Chen
Jan 11, 2014·Current Hematologic Malignancy Reports·Paolo Neviani
Feb 7, 2014·Current Hematologic Malignancy Reports·Andreas Burchert
Mar 1, 2014·Nature Reviews. Drug Discovery·Kian Hoe KhooDavid P Lane
Oct 8, 2013·Oncogene·S J VidalJ Domingo-Domenech
Jul 4, 2013·Molecular Aspects of Medicine·Samanta A Mariani, Bruno Calabretta
Oct 24, 2014·Cell Death & Disease·L MaB Brodin
Sep 25, 2012·Expert Opinion on Therapeutic Targets·Varun V PrabhuWafik S El-Deiry
Jun 8, 2015·Current Opinion in Hematology·Ling Li, Ravi Bhatia
Oct 4, 2014·Cell Stem Cell·Bernd B Zeisig, Chi Wai Eric So
Dec 5, 2013·Cancer Investigation·Marcos Vinícius Macedo de OliveiraSérgio Henrique Sousa Santos
Oct 30, 2012·Free Radical Biology & Medicine·Brian J Morris
Aug 22, 2012·Cancer Letters·Leslie A Crews, Catriona H M Jamieson
Jun 27, 2012·Biochemical and Biophysical Research Communications·Basant Kumar ThakurPrakash Chandra
Jun 12, 2012·Molecular and Cellular Endocrinology·Luciano PirolaFlorence Solari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.